Bio-Medical Applications Of North Carolina, Inc. in Charlotte, North Carolina - Dialysis Center

Bio-Medical Applications Of North Carolina, Inc. is a medicare approved dialysis facility center in Charlotte, North Carolina and it has 12 dialysis stations. It is located in Mecklenburg county at 6646 Regal Oaks Drive, Charlotte, NC, 28212. You can reach out to the office of Bio-Medical Applications Of North Carolina, Inc. at (704) 535-7231. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of North Carolina, Inc. has the following ownership type - Profit. It was first certified by medicare in May, 2017. The medicare id for this facility is 342719 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of North Carolina, Inc.
Location	6646 Regal Oaks Drive, Charlotte, North Carolina
No. of Dialysis Stations	12
Medicare ID	342719
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of North Carolina, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1235585704
Organization Name	Fresenius Kidney Care Regal Oaks
Doing Business As	Bio-medical Applications Of North Carolina, Inc.
Address	6646 Regal Oaks Dr Charlotte, North Carolina, 28212
Phone Number	(704) 535-7231

NPI Number	1851891774
Organization Name	Fresenius Medical Care Aldersgate
Doing Business As	Bio-medical Applications Of North Carolina, Inc.
Address	3201 Bishops Way Lane Charlotte, North Carolina, 28215
Phone Number	(704) 591-3792

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	13
  Adult patient months included in Kt/V greater than or equal to 1.2	31
  Percentage of adult patients getting regular hemodialysis at the center	74
  Percentage of pediatric patients getting regular hemodialysis at the center

• Peritoneal Dialysis

  Adult patients getting regular peritoneal dialysis at the center	1
  Adult patient months included in Kt/V greater than or equal to 1.7	4
  Percentage of adult patients getting regular peritoneal dialysis at the center
  Percentage of pediatric patients getting regular peritoneal dialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of North Carolina, Inc. with elevated calcium levels.

Patients with hypercalcemia	14
Hypercalcemia patient months	37
Patients with Serumphosphor	17
Patients with Serumphosphor less than 3.5 mg/dL	12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	15
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	35
Patients with Serumphosphor from 5.6 to 7 mg/dL	26
Patients with Serumphosphor greater than 7 mg/dL	12

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	10
Patient months included in arterial venous fistula and catheter summaries	27
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer